Two Sigma Securities LLC Invests $1.77 Million in Agilent Technologies, Inc. $A

Two Sigma Securities LLC purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 13,308 shares of the medical research company’s stock, valued at approximately $1,768,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp boosted its stake in Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after purchasing an additional 241,029 shares during the period. Wellington Management Group LLP grew its holdings in Agilent Technologies by 2.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after buying an additional 198,253 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after buying an additional 25,139 shares during the period. Deutsche Bank AG increased its position in shares of Agilent Technologies by 17.1% during the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after buying an additional 1,024,516 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares in the last quarter.

Agilent Technologies Stock Up 0.4%

Shares of NYSE A opened at $154.47 on Monday. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The business has a 50-day moving average of $140.30 and a 200-day moving average of $127.04. The firm has a market capitalization of $43.63 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.34 and a beta of 1.25. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $163.75.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period last year, the firm posted $1.37 earnings per share. Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on A. Citigroup raised their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday. Morgan Stanley upped their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Bank of America raised their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday. Finally, Piper Sandler began coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.